Use of computed tomography and bone scans in low-risk prostate cancer cases has been in decline, but doctors continue to order these imaging modalities despite professional guidelines that do not recommend such use.
Ga 68 PSMA-11 PET can detect sites of local recurrence or metastasis in patients with biochemical evidence of recurrent prostate cancer.
In a study, a positive PSMA PET/CT scan was associated with a significant 4.5-fold higher adjusted risk for disease progression.
In a study of men on active surveillance for low-risk prostate cancer, multiparametric magnetic resonance imaging by itself missed about one-fifth of men who had pathologic upgrading on subsequent biopsies.
Comprehensive strategy for safe resumption should consider local COVID-19 statistics, PPE availability.
Increased subspecialization seen across cohorts defined by gender, years in practice, practice size.
The potential diagnostic harms of withholding group II gadolinium-based contrast agents may outweigh the risk of nephrogenic systemic fibrosis in advanced CKD patients, according to investigators.
Confirmatory biopsy with MRI guidance provides a more accurate risk assessment than a conventional transrectal ultrasound confirmatory biopsy, according to researchers.
In a study, combining targeted and systematic biopsy detected 11% to 33% more prostate cancers than either method alone.
Nearly half of patients with autosomal dominant polycystic kidney disease receive at least 1 CT scan over 2 years, study finds.
